# Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty

> **NCT05962970** · NA · UNKNOWN · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Total Knee Arthroplasty

## Interventions

- **DRUG:** continuous adductor canal block (CACB) ropivacaine
- **DRUG:** sham continuous adductor canal block - ShACB NaCl

## Key facts

- **NCT ID:** NCT05962970
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-04
- **Primary completion:** 2024-08-03
- **Final completion:** 2024-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05962970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05962970, "Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05962970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*